The AKT1 gene gives your cells instructions for a protein that helps control growth, survival, and energy use. In medicine, this gene is important because it helps regulate how cells respond to signals telling them when to grow or rest. If AKT1 activity becomes too strong or poorly controlled, some cells may keep growing when they should not. Certain variants in the AKT1 gene are linked to patchy body overgrowth, including Proteus syndrome, and AKT1 changes can also play a role in some cancers.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, which are the working parts of cells. Other genes mostly help determine when certain processes happen, where they happen, and how strongly they take place. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
AKT1Gene function
What if the gene works
The AKT1 gene helps cells respond to growth signals. Its protein supports cell growth, survival, and sugar use, helping tissues develop and repair in a controlled way.
Risk
What if the gene does not work
Certain variants in the AKT1 gene can cause Proteus syndrome, with patchy overgrowth of bone, skin, and other tissues. Other AKT1 variants can help drive some cancers. Effects may range from mild to more marked, depending on the variant.
Treatment
What does that mean for your treatment
Certain AKT1 variants can affect drug choice in some HR-positive, HER2-negative advanced breast cancers, where capivasertib plus fulvestrant may be an option after endocrine therapy. Outside these specific settings, no AKT1-specific treatment approach is established, though AKT targeted drugs are under study in other cancers and in Proteus syndrome.
Conditions associated with AKT1
Gene function
What if the gene works
In everyday cell life, the AKT1 gene helps cells respond to signals that say grow, use energy, or keep working. Its protein acts as an internal relay, linking outside messages to changes inside the cell. Understanding how the AKT1 gene works in the body helps explain how cells balance growth, metabolism, and routine maintenance.
Cells use the AKT1 gene to pass along messages from insulin and other growth signals at the cell surface. This relay helps cells adjust their activity to match the body's needs.
AKT1 activity supports protein building and other steps that help cells grow in a controlled way. It helps coordinate growth with available nutrients and outside signals.
This gene helps cells decide when to take in sugar from the blood and turn nutrients into usable energy. That supports everyday energy balance in many tissues.
AKT1 sends signals that help cells stay active during normal stresses and routine wear. It supports repair and maintenance pathways that keep cells functioning day to day.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AKT1 gene usually affect how strongly the AKT1 protein sends growth and survival signals inside cells. Some changes have a mild effect, while activating variants such as AKT1 p.Glu17Lys can make the protein switch on easily, stay active longer, or attach abnormally to cell membranes. This shows how AKT1 gene variants affect cell signaling, and stronger activating changes may be linked to more pronounced tissue overgrowth when only some cells carry the variant, or to tumor growth.
How variants are linked to conditions
Among conditions linked to AKT1 gene variants, Proteus syndrome is the clearest and most established. A specific pathogenic variant that arises after conception causes this rare condition, which can lead to patchy overgrowth in different parts of the body. Separate acquired AKT1 variants are also found in some cancers, including breast and endometrial cancer, usually as changes in the tumor rather than an inherited cancer syndrome.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are common across the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or lower health risks related to the AKT1 gene. Risk depends mostly on the exact AKT1 change and where it is found in the body, rather than on day-to-day habits. Anyone worried about personal risk should speak with a doctor or genetic counselor.
Inheritance of AKT1 variants
For AKT1 inheritance, there is no usual inherited family pattern for the best-known AKT1-related condition, Proteus syndrome. In most people with this condition, the AKT1 variant arises as a new mosaic variant after conception, so it is generally not passed down from a parent and usually does not run in families. The AKT1 gene is located on chromosome 14, which is an autosome, so each person has two copies overall, one inherited from each parent.
What does my AKT1 result mean for my family?
There is not a broadly confirmed inherited family pattern for AKT1 tied to a specific condition. Most known AKT1 changes linked to Proteus syndrome happen by chance after conception rather than being passed down, so they usually do not run in families.
Genetic information
Genetic testing
How you find out about variants
AKT1 genetic testing looks for changes in the AKT1 gene using a blood, saliva, or cheek swab sample. A lab reads the gene’s DNA code to check for variants and reports whether a finding is linked with an AKT1 related condition, is uncertain, or is not clinically significant.
When should I consider getting a genetic test?
If there are signs of Proteus syndrome, a rare condition that causes some body parts to grow too much and unevenly, AKT1 testing may help confirm the cause. AKT1 may also be checked in tumor testing for some cancers, especially breast cancer, because the result can affect treatment choices.
A genetic result is only one part of your health story
A genetic result can give valuable information, though how much it explains varies by the condition and the specific type of variant. Over time, many other factors also affect how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences shape the way a person responds to medication. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can affect how strongly a drug works or how the body processes it. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the AKT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so concerns about side effects, poor response to treatment, or questions before starting a new medicine are best discussed with your doctor. AKT1 is being studied mainly in cancer care, where changes in cancer cells can sometimes help guide targeted treatment decisions.
History
AKT1 entered cancer research through studies of a virus linked to tumors in mice, which led scientists to a related human gene in the late 1980s. Early work placed the AKT1 gene among a small group of genes that helped reshape how researchers thought about cell growth and cancer. From these first observations, research expanded steadily. During the 1990s and 2000s, AKT1 became a central part of the rapidly growing PI3K and AKT signaling story, a major shift in modern cancer biology. Its history also includes landmark reports of specific AKT1 variants in some tumors and in rare overgrowth conditions, which widened medical interest beyond oncology. Today, AKT1 remains one of the better known genes from that era of cancer genetics.